Weed to Know – Need to Know: Cannabis (Marijuana) in Pregnancy & Lactation

The percentage of Tetrahydrocannabinol (THC) in cannabis has increased nearly ten times since the earliest studies relating long term outcomes of prenatal use have been reported. New data confirm brain changes in the amygdala of fetuses of women who have used cannabis in early pregnancy. Neurodevelopmental changes that may be observed at birth, as well as strategies for care, will be discussed. Prenatal exposure increases the risk of being smaller, born prematurely and admitted to the neonatal intensive care unit (NICU). 

Recently, pregnant and breast-feeding women have increased the use of CBD, another cannabis compound. Complexities of the use of Cannabidiol (CBD) will also be presented. Strategies for counseling women who question perinatal cannabis and CBD use will be presented with evidence. Multiple statements of professional organizations, regarding perinatal use of cannabis and CBD while pregnant or breastfeeding, will support counseling.


Time-ordered Agenda:

0:00 to 0:15 min: Cannabis use in pregnancy

0:15 to 0:30 min: Fetal brain changes

0:30 to 0:45 min: Newborn and child outcomes of prenatal cannabis exposure

0:45 to 0:60 min: Differentiation of THC and CBD use in pregnancy and outcomes

1:00 to 1:20 min: Question and answer session (Live on December 1, 2020, will be viewed as recording after live event)

1:20 to 1:30 min: Learning assessment


Educational Level: Intermediate
Instructional Methods: Live webinar with lecture, case studies, question and answer session and learning assessment. Recorded webinar includes lecture, case studies, recorded question and answer session and learning assessment. 
Target Audience: OT, SLP, PT, RN, MD, and neonatal professionals


 Participants will:

  1. Differentiate the cannabinoids TetraHydroCannabinol (THC) and Cannabidiol (CBD).
  2. Describe potential outcomes for children exposed prenatally to cannabis.
  3. Relate the US Surgeon General, FDA, AAP, ACOG, AWHONN and Breast-Feeding Medicine recommendations regarding marijuana/cannabis and CBD use in pregnancy and breastfeeding.

Learners must view the entire webinar, complete the course evaluation and pass the learning assessment with an 80% or higher to receive education credit and a certificate of completion. Login and logout times will be recorded and documented. 

For ADA accommodations, please call NANT Customer Service for more information at (866) 999-5524.

Please click here to review the NANT Cancellation Policy